GO:0034260 negative regulation of GTPase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034260 describes any process that stops or reduces the rate of GTP hydrolysis by a GTPase, keeping small GTPases in their active GTP-bound state.
• Negative regulation of GTPase activity is achieved mainly by GTPase-activating protein (GAP) inhibition, guanine nucleotide exchange factor (GEF) activation, or direct post-translational modification of the GTPase.
• Key GTPase families regulated by this process include Rho (RhoA, Rac1, Cdc42), Ras, Rab, Ran and Rag GTPases.
• Dysregulation of this process drives cancer, neurodegeneration, immune dysfunction and metabolic disease.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect causal roles of GAPs, GEFs and GTPases in this pathway.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study negative regulation of GTPase activity at scale.
Description
GO:0034260, negative regulation of GTPase activity, is a biological process that stops or reduces the rate of GTP hydrolysis by a GTPase, thereby prolonging the active GTP-bound state of small GTPases. Small GTPases such as RhoA, Rac1, Cdc42, Rab8 and Rag GTPases act as molecular switches in signal transduction, cytoskeletal dynamics, vesicle trafficking and nutrient sensing. Their activity is tightly controlled by the opposing actions of guanine nucleotide exchange factors (GEFs), which promote GTP loading, and GTPase-activating proteins (GAPs), which accelerate GTP hydrolysis. Negative regulation of GTPase activity therefore occurs when GAP function is inhibited, when GEF activity dominates, or when the GTPase itself is modified to resist hydrolysis. This process is central to many physiological and pathological contexts. For example, p190RhoGAP regulates Rho GTPase activity at the leading edge of migrating cells, and its inhibition sustains RhoA-GTP to control motility. The metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer, illustrating how oncogenic signaling can suppress GTP hydrolysis. Optineurin mediates negative regulation of Rab8 by the GAP TBC1D17, linking this process to vesicle trafficking and autophagy. The GATOR1 complex acts as a GAP for Rag GTPases, and its inhibition by amino acid sufficiency leads to negative regulation of Rag GTPase activity and mTORC1 activation. For researchers, GO:0034260 provides a framework to study how cells maintain active GTPase pools. Understanding this process requires integrating structural biology, live-cell imaging, biochemical GTP hydrolysis assays and CRISPR-based genetic models. This article reviews the definition, mechanism, key genes, disease links and research methods for negative regulation of GTPase activity, with a focus on publication-ready experimental design.
negative regulation of GTPase activity At A Glance
| GO ID | GO:0034260 |
|---|---|
| GO term | negative regulation of GTPase activity |
| Ontology | biological_process |
| Definition | Any process that stops or reduces the rate of GTP hydrolysis by a GTPase. |
| Synonym | inhibition of GTPase activity; negative regulation of Ras GTPase activity; negative regulation of Rho GTPase activity; negative regulation of Rab GTPase activity; negative regulation of Ran GTPase activity |
| Major function | Maintains small GTPases in their active GTP-bound state by reducing GTP hydrolysis. |
| GTPase families | Rho, Ras, Rab, Ran and Rag GTPases. |
| Key regulators | GAPs (e.g., p190RhoGAP, TBC1D17, GATOR1), GEFs (e.g., Ephexin5), and post-translational modifiers. |
| Disease relevance | Cancer, neurodegeneration, immune disorders and metabolic disease. |
What Is GO:0034260?
Negative regulation of GTPase activity (GO:0034260) is any process that stops or reduces the rate of GTP hydrolysis by a GTPase. In practical terms, it shifts the balance of a small GTPase toward its GTP-bound, active conformation by inhibiting GAPs, activating GEFs, or modifying the GTPase to slow hydrolysis.
Why Is negative regulation of GTPase activity Important in Cell Biology?
Negative regulation of GTPase activity is important because it controls the duration and amplitude of small GTPase signaling, which in turn governs cell migration, proliferation, vesicle trafficking, autophagy, immune cell memory and nutrient sensing. When this process is dysregulated, GTPases can remain constitutively active, driving oncogenesis, neurodegeneration or metabolic dysfunction.
• Controls cell migration by regulating RhoA-GTP levels at the leading edge.
• Promotes cancer progression through Rac1 activation by LDHA.
• Supports T cell memory development via AMPK-SENP1-Sirt3 signaling.
• Regulates synapse growth and stabilization through Cdc42.
• Controls mTORC1 signaling via Rag GTPases and GATOR1.
• Modulates endosomal phosphatidylinositol-4,5-bisphosphate via RAB-10.
• Regulates Rab8-dependent trafficking and autophagy via optineurin and TBC1D17.
• Provides targets for CRISPR screens to identify GAPs and GEFs.
• Links metabolic state to GTPase activity in immune cells.
• Offers therapeutic opportunities in cancer and neurodegeneration.
What Happens During negative regulation of GTPase activity?
Inhibition of GTPase-activating proteins (GAPs)
In simple terms: GAPs normally speed up GTP hydrolysis; blocking them keeps GTPases active.
GAPs accelerate the intrinsic GTP hydrolysis of small GTPases, converting them to the inactive GDP-bound state. Negative regulation of GTPase activity often occurs when GAPs are inhibited or sequestered. For example, p190RhoGAP regulates Rho GTPase activity at the leading edge of migrating cells, and its local inhibition sustains RhoA-GTP. Similarly, optineurin mediates negative regulation of Rab8 by the GAP TBC1D17, and disruption of this axis alters Rab8 activity.
Activation of guanine nucleotide exchange factors (GEFs)
In simple terms: GEFs help GTPases load GTP; activating them shifts the balance toward the active state.
GEFs promote the exchange of GDP for GTP, indirectly opposing GTP hydrolysis. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization, demonstrating how GEF activation can sustain Cdc42-GTP. In cancer, LDHA activates Rac1 GTPase as a noncanonical mechanism, further illustrating GEF-independent activation that reduces GTP hydrolysis.
Post-translational modification of GTPases
In simple terms: Chemical changes to a GTPase can make it harder to hydrolyze GTP.
Phosphorylation, ubiquitination, SUMOylation and other modifications can alter GTPase stability or catalytic activity. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development, linking metabolic stress to post-translational control of GTPase-related pathways. Such modifications can reduce GTP hydrolysis and prolong active GTPase signaling.
Sequestration and scaffolding
In simple terms: Binding partners can hide GTPases from GAPs or hold them in active conformations.
Scaffold proteins and effector binding can sequester GTPases away from GAPs or stabilize the GTP-bound state. RAB-10-GTPase-mediated regulation of endosomal phosphatidylinositol-4,5-bisphosphate involves membrane recruitment and effector interactions that influence GTP hydrolysis. The GATOR1 complex acts as a GAP for Rag GTPases, and its inhibition by amino acid sufficiency leads to negative regulation of Rag GTPase activity.
Integration with cellular signaling
In simple terms: This process is wired into nutrient, metabolic and immune signals.
Negative regulation of GTPase activity is not isolated; it is integrated with mTORC1, AMPK and other signaling hubs. The tumor suppressor complex GATOR1 provides GAP activity for Rag GTPases that signal amino acid sufficiency to mTORC1, and its loss causes constitutive Rag activation. Synthetic negative genome screens in Saccharomyces cerevisiae have identified GPN-loop GTPase NPA3 regulators, showing conserved mechanisms.
Key Genes Involved in GO:0034260 negative regulation of GTPase activity
The following genes and proteins are central to negative regulation of GTPase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RhoA | Rho GTPase regulated by p190RhoGAP at the leading edge | Cell migration and cytoskeletal dynamics |
| Rac1 | Rho GTPase activated by LDHA in cancer | Oncogenic signaling and metabolism |
| Cdc42 | Rho GTPase regulated by Ephexin5 in neurons | Synapse growth and stabilization |
| Rab8 | Rab GTPase negatively regulated by optineurin and TBC1D17 | Vesicle trafficking and autophagy |
| RagA/RagB/RagC | Rag GTPases controlled by GATOR1 GAP activity | mTORC1 signaling and nutrient sensing |
| RAB-10 | Rab GTPase regulating endosomal PI(4,5)P2 | Endosomal trafficking |
| p190RhoGAP | GAP for RhoA | Regulation of Rho GTPase activity |
| TBC1D17 | GAP for Rab8 | Negative regulation of Rab8 |
| GATOR1 (DEPDC5, NPRL2, NPRL3) | GAP complex for Rag GTPases | mTORC1 signaling |
| Ephexin5 | GEF for Cdc42 | Activity-dependent Cdc42 regulation |
| LDHA | Metabolic enzyme activating Rac1 | Cancer metabolism |
| Optineurin | Mediates negative regulation of Rab8 | Autophagy and trafficking |
| SENP1 | DeSUMOylase in AMPK-Sirt3 signaling | T cell memory development |
| Sirt3 | Mitochondrial deacetylase | Metabolic regulation |
| AMPK | Energy sensor kinase | Glucose limitation response |
| NPA3 | GPN-loop GTPase in yeast | Synthetic negative genome screens |
How Is negative regulation of GTPase activity Regulated?
Negative regulation of GTPase activity is itself regulated by upstream signals. Amino acid sufficiency inhibits GATOR1 GAP activity toward Rag GTPases, leading to negative regulation of Rag GTPase activity and mTORC1 activation. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development, linking metabolic stress to GTPase regulation. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization, showing neuronal activity controls this process. In migrating cells, p190RhoGAP is locally regulated to control Rho GTPase activity at the leading edge.
negative regulation of GTPase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Rac1 | Cancer metabolism and metastasis | LDHA knockout or Rac1 point-mutation cell lines |
| RagA/RagB/RagC | mTORC1-driven tumors and epilepsy | GATOR1 knockout or Rag GTPase knock-in models |
| Rab8 | Neurodegeneration and autophagy defects | Optineurin or TBC1D17 knockout cells |
| Cdc42 | Synaptic dysfunction and neurodevelopmental disorders | Ephexin5 knockout or Cdc42 point-mutation neurons |
| RhoA | Cancer cell migration and invasion | p190RhoGAP knockout or overexpression models |
Cancer
Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer, demonstrating how negative regulation of GTPase activity can drive oncogenesis. Loss of GATOR1 GAP activity leads to constitutive Rag GTPase activation and mTORC1 signaling, which is linked to cancer and epilepsy. Targeting these mechanisms may offer therapeutic opportunities.
Neurodegeneration and neurological disorders
Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17, and optineurin mutations are associated with neurodegeneration. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization, implicating this process in synaptic plasticity and neurological disease.
Immune and metabolic disorders
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development, connecting negative regulation of GTPase activity to immune memory and metabolic disease. Dysregulation of this process may contribute to autoimmunity and metabolic syndrome.
From negative regulation of GTPase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a GAP increase GTPase activity? | CRISPR knockout of the GAP gene |
| Does a point mutation in the GTPase alter hydrolysis? | Point-mutation knock-in of the GTPase |
| Does a disease-associated variant affect GTPase regulation? | Knock-in of the variant allele |
| Where is the GTPase active in cells? | Tagged knock-in with a GTPase biosensor |
| Does overexpression of a GEF activate the GTPase? | Overexpression cell model |
| Which genes regulate this process genome-wide? | CRISPR library screening |
How to Study the negative regulation of GTPase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GTP hydrolysis assay | Rate of GTP hydrolysis | Testing GAP activity and negative regulators |
| FRET biosensor imaging | GTPase activity in live cells | Spatiotemporal dynamics |
| CRISPR knockout | Loss-of-function effects | Identifying GAP/GEF function |
| CRISPR library screen | Genome-wide regulators | Discovery of new pathway components |
| Co-immunoprecipitation | Protein-protein interactions | Mapping GAP-GTPase complexes |
| Phosphoproteomics | Post-translational modifications | Identifying regulatory modifications |
| RNA-seq | Transcriptional changes | Downstream effects of GTPase activation |
| Metabolomics | Metabolic state | Linking metabolism to GTPase regulation |
Biochemical GTP hydrolysis assays
In vitro GTP hydrolysis assays using purified GTPases and GAPs measure the rate of GTP hydrolysis and the effect of negative regulators. These assays are foundational for studying GO:0034260.
Live-cell imaging with GTPase biosensors
FRET-based or dimerization-based biosensors visualize GTPase activity in living cells. Activity-dependent regulation of Cdc42 by Ephexin5 was studied using such approaches. p190RhoGAP regulation of RhoA at the leading edge was also visualized by imaging.
CRISPR screens and functional genomics
Synthetic negative genome screens in Saccharomyces cerevisiae identified regulators of the GPN-loop GTPase NPA3, demonstrating the power of CRISPR-based screens for this process. Similar screens in mammalian cells can identify GAPs and GEFs.
Proteomics and interactomics
Affinity purification and mass spectrometry identify GAP and GEF complexes. The GATOR1 complex was identified as a GAP for Rag GTPases using biochemical and proteomic approaches. Optineurin-TBC1D17 interactions were mapped by co-immunoprecipitation.
How CRISPR Can Be Used to Study GO:0034260 negative regulation of GTPase activity
Knockout
CRISPR knockout of GAPs such as p190RhoGAP or TBC1D17 removes negative regulation, leading to increased GTPase activity. This is used to test causal roles in migration, trafficking and signaling.
Point Mutation
Point mutations in GTPases (e.g., Rac1, Cdc42) that impair GTP hydrolysis create constitutively active alleles. These models are used to study oncogenic and synaptic effects.
Knock-in
Knock-in of disease-associated variants in Rag GTPases or optineurin allows study of altered regulation in isogenic backgrounds.
Overexpression
Overexpression of GEFs such as Ephexin5 or metabolic enzymes like LDHA drives GTPase activation and is used to model cancer and neuronal signaling.
How EDITGENE Supports negative regulation of GTPase activity Research
Researchers studying negative regulation of GTPase activity-related genes often need to determine whether a candidate gene is causally involved in GTPase regulation, whether a specific mutation alters hydrolysis, or whether overexpression is sufficient to drive a phenotype. EDITGENE provides the CRISPR cell models and screening services to answer these questions rigorously.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of GTPase activity research.
Frequently Asked Questions About negative regulation of GTPase activity
What is negative regulation of GTPase activity?
It is any process that stops or reduces the rate of GTP hydrolysis by a GTPase, keeping the GTPase in its active GTP-bound state.
What is the GO ID for negative regulation of GTPase activity?
The GO ID is GO:0034260.
What genes are involved in negative regulation of GTPase activity?
Key genes include RhoA, Rac1, Cdc42, Rab8, Rag GTPases, p190RhoGAP, TBC1D17, GATOR1, Ephexin5, LDHA and optineurin.
How is GTPase activity negatively regulated?
It occurs through GAP inhibition, GEF activation, post-translational modification or sequestration of the GTPase.
Which diseases are linked to negative regulation of GTPase activity?
Cancer, neurodegeneration, immune disorders and metabolic disease are linked to this process.
What is the role of GATOR1 in this process?
GATOR1 is a GAP complex for Rag GTPases; its inhibition leads to negative regulation of Rag GTPase activity and mTORC1 activation.
How can I study negative regulation of GTPase activity?
Use GTP hydrolysis assays, live-cell biosensors, CRISPR knockouts, point mutations and library screens.
What CRISPR models are available for this pathway?
Knockout, point mutation, knock-in, overexpression and library screening models are available.
Does LDHA regulate Rac1 GTPase?
Yes, LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer.
What is the role of optineurin in Rab8 regulation?
Optineurin mediates negative regulation of Rab8 by the GTPase-activating protein TBC1D17.
Conclusion
Negative regulation of GTPase activity (GO:0034260) is a fundamental process that controls the active lifetime of small GTPases, influencing cell migration, trafficking, immune memory, neuronal signaling and nutrient sensing. Its dysregulation contributes to cancer, neurodegeneration and metabolic disease. CRISPR-based models and functional screens are essential to dissect the causal roles of GAPs, GEFs and GTPases in this pathway. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Bidaud-Meynard A et al.. 2019. Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.. Small GTPases 10(2):99-110 PMID: 28287334
- 2. Liu J et al.. 2022. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer.. Nat Metab 4(12):1830-1846 PMID: 36536137
- 3. He J et al.. 2021. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.. Nat Commun 12(1):4371 PMID: 34272364
- 4. Petshow S et al.. 2025. Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization.. Sci Adv 11(13):eadp5782 PMID: 40138406
- 5. Bar-Peled L et al.. 2013. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.. Science 340(6136):1100-6 PMID: 23723238
- 6. Shi A et al.. 2012. RAB-10-GTPase-mediated regulation of endosomal phosphatidylinositol-4,5-bisphosphate.. Proc Natl Acad Sci U S A 109(35):E2306-15 PMID: 22869721
- 7. Vaibhava V et al.. 2012. Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17.. J Cell Sci 125(Pt 21):5026-39 PMID: 22854040
- 8. Mora-García M et al.. 2022. Synthetic negative genome screen of the GPN-loop GTPase NPA3 in Saccharomyces cerevisiae.. Curr Genet 68(3-4):343-360 PMID: 35660944
